Danyu Du
China Pharmaceutical University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, Computational Drug Discovery Methods, RNA modifications and cancer, MicroRNA in disease regulation
Most-Cited Works
- → Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma(2021)575 cited
- → The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer(2020)99 cited
- → Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop(2017)90 cited
- → The comprehensive landscape of miR-34a in cancer research(2021)83 cited
- → Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner(2020)32 cited
- → MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells(2016)32 cited
- → Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China(2021)25 cited
- → RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression(2023)19 cited
- → C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma(2021)19 cited
- GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway(2022)